The products include:
- A new version of the TxCell™ Pattern Scanning Laser Delivery System. The new iteration of the high-speed delivery device is compatible with the largest market of physician-owned slit lamps.
- A new IRIDEX MicroPulse Laser Trabeculoplasty (MLT) lens manufactured by Ocular Instruments. The new product, distributed exclusively through
IRIDEX , is designed to increase efficiency and precision of MLT for the treatment of glaucoma. - A portfolio of single-use 27-gauge laser probes, Peregrine Surgical-branded, that are compatible with the growing number of 27-gauge vitrectomy systems used in retina surgery.
- A GreenTip™ Membrane Scraper, available in 23 & 25 gauges, offering a single-use surgical device intended for specialized retinal surgery. The new device is designed to maximize visualization against the retina and is a derivative of the proprietary GreenTip product family.
"These are each significant new products that represent what we see as important niches and opportunities in the ophthalmology marketplace," said
To schedule a demonstration of
- MicroPulse Laser in the Forefront of Macular Disease Treatment (in Portuguese), presented by
Alessandro Dare , M.D., Ph.D., head ofRetina Department of Hospital Olhos do Interior Paulista,Sao Paulo, Brazil ; andRenato Peroni , M.D.,Retina Department , Ophthalmology,Santa Casa de Jau ,Sao Paulo ; Hospital de Ohlos de Araraquara, Araraquara,Sao Paulo ,Ophthalmology Department University ofSao Paulo ;10 a.m. Sunday, Nov. 17 . - Laser-Assisted, Non-Incisional Glaucoma Therapy Benefits of Versatile Laser Systems for TSCPC & MLT Procedures in the MIGS World, presented by
Iqbal (Ike) Ahmed , MD, FRCSC, Assistant Professor and Research Fellowship Director,Department of Ophthalmology ,University of Toronto ; andNathan M. Radcliffe , M.D., Assistant Professor of Ophthalmology,Weill Cornell Medical College ,New York-Presbyterian Hospital ;1 p.m. Sunday, Nov. 17 . - MicroPulse Laser Therapy for the Comprehensive Ophthalmologist: From the Anterior to the Posterior Segment, presented by
David Gossage , D.O., FAOCO, FAAO, Medical Director,Gossage Eye Institute ,Hillsdale, MI ;1 p.m. Saturday Nov. 16 .
For a complete program of speakers, go to http://www.iridex.com/speakersforum. The
About
Safe Harbor Statement
This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, relating to the Company's anticipated product releases and the markets for the Company's products. These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors. Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended
SOURCE
IRIDEX Contact: Jim Mackaness, CFO & COO, 650-940-4700, Investor Relations Contact, Matt Clawson, Allen & Caron, 949-474-4300, matt@allencaron.com